- CH₣892.19m
- CH₣721.85m
- €104.17m
Brief: Cosmo Pharmaceuticals Announces United Arab Emirates Regulatory Approval Of GI GENIUS(TM)
Brief: Cosmo Pharmaceuticals Increases Its Stake In Acacia Pharma To 18.53%
Swiss stocks - Factors to watch on June 2
Europe Research Roundup: Aker BP ASA, Diageo, Remy Cointreau
Swiss stocks - Factors to watch on April 20
Brief: Cosmo Pharmaceuticals Announces Approval For Opaganib As Treatment Of Covid-19 In Italy
Brief: Cosmo Pharmaceuticals FY Net Loss Widens To EUR 24.5 Mln
Brief: Cosmo Files Protocol For Confirmatory Phase III Trial For Methylene Blue
Brief: Cosmo Pharmaceuticals: FDA Extends NDA Review Period For BYFAVO(TM)
Brief: Cosmo Pharmaceuticals Announces Australian Regulatory Approval Of GI Genius
Brief: Cosmo Pharmaceuticals Aligns With FDA On Methylene Blue MMX Second Phase III Study
Europe Research Roundup: Homeserve, Puma, Ted Baker
Brief: Acacia Pharma Partners With Cosmo Pharmaceuticals
Swiss stocks - Factors to watch on Jan 10
Brief: Cosmo Pharmaceuticals Sub-Licenses Its ByFavo US Rights To Acacia Pharma
Brief: Cosmo Pharmaceuticals Announces Distribution Agreement For Eleview With Medtronic
RedHill Biopharma: Rises on Cosmo Pharmaceuticals collaboration
Swiss stocks - Factors to watch on Otober 18
Brief: Cosmo Licenses Aemcolo For USA And Takes Stake In RedHill Biopharma